Tuesday, July 8, 2025
HomeTagsBiotechnology

Biotechnology

Growlab Pharmaceuticals Achieved High Remission on Clinical Trials of Comacadine for Treatment of Diabetes Mellitus

GrowLab Pharmaceuticals PLC ("GrowLab") recorded 96% Clinical Diabetes Remission following independent clinical trials of its phytocannabinoids based therapeutic Comacadine curated and synthesised from its...

EpiVax and Massachusetts General Hospital Advance on T cell-Targeted Epitope Vaccine for Q Fever

EpiVax, Inc. ("EpiVax") announces the publication "Evaluation of a Human T Cell-Targeted Multi-Epitope Vaccine for Q Fever in Animal Models of Coxiella burnetii Immunity"...

NRx Pharmaceuticals Announces Data Safety Monitoring Board (DSMB) Update on U.S. National Institutes of Health (NIH) Study of ZYESAMI (aviptadil) in Critical COVID-19

NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, announced results of a review conducted by the Data Safety and Monitoring Board (DSMB) on May 25,...

SeekIn Receives CE Mark Approval for SeekInClarity Cancer Treatment Response Monitoring Kit

SeekIn Inc, a leader in blood-based cancer early detection and monitoring technology, announced CE (ConformitéEuropéenne) Mark approval for SeekInClarityTM Cancer Treatment Response Monitoring Kit...

Elevai Labs, Inc. Is Pleased to Announce It Has Retained Leading Wall Street Investment Bank Univest Securities, LLC.

ELEVAI LABS, INC., ("ELEVAI" or the "Company") a science-based, data-driven regenerative aesthetic skincare company is pleased to announce it has retained Univest Securities, LLC...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics